Terms: = Lung cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
2087 results:
1. Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor.
Hua X; Feng W; Ye M; Lai M; Yu X; Sun M; Li J; Ai R; He Y; Cai L; Shi C; Liu X
Cancer Med; 2024 May; 13(9):e7206. PubMed ID: 38686619
[TBL] [Abstract] [Full Text] [Related]
2. Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA.
Wang H; Wang J; Liu Y; Wang Y; Zhou Y; Yu D; You H; Ren T; Tang Y; Wang M
Diagn Pathol; 2024 Apr; 19(1):61. PubMed ID: 38641621
[TBL] [Abstract] [Full Text] [Related]
3. Alectinib in Resected
Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
[TBL] [Abstract] [Full Text] [Related]
4. High risk of lung cancer in surfactant-related gene variant carriers.
Brudon A; Legendre M; Mageau A; Bermudez J; Bonniaud P; Bouvry D; Cadranel J; Cazes A; Crestani B; Dégot T; Delestrain C; Diesler R; Epaud R; Philippot Q; Théou-Anton N; Kannengiesser C; Ba I; Debray MP; Fanen P; Manali E; Papiris S; Nathan N; Amselem S; Gondouin A; Guillaumot A; Andréjak C; Jouneau S; Beltramo G; Uzunhan Y; Galodé F; Westeel V; Mehdaoui A; Hirschi S; Leroy S; Marchand-Adam S; Nunes H; Picard C; Prévot G; Reynaud-Gaubert M; De Vuyst P; Wemeau L; Defossez G; Zalcman G; Cottin V; Borie R;
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38575158
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study.
Li QY; Yang WX; Liu H; Yao JL; Wang Q; Lin D; Shi J
Cancer Med; 2024 Apr; 13(7):e7147. PubMed ID: 38562035
[TBL] [Abstract] [Full Text] [Related]
6. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
[TBL] [Abstract] [Full Text] [Related]
7. lung cancer Diagnoses and Outcomes During the Syrian War, 2011-2018.
Hanafi I; Abo Samra D; Alsaqqa R; Naeem A; Shebli B; Ajlyakin G
JAMA Netw Open; 2024 Mar; 7(3):e242091. PubMed ID: 38477917
[TBL] [Abstract] [Full Text] [Related]
8. Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis.
Jin X; Pan Y; Zhai C; Shen H; You L; Pan H
Sci Rep; 2024 Feb; 14(1):4793. PubMed ID: 38413705
[TBL] [Abstract] [Full Text] [Related]
9. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
[TBL] [Abstract] [Full Text] [Related]
10. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
[TBL] [Abstract] [Full Text] [Related]
11. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
Cheng J; Zhou L; Wang H
Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes Of Surgically Treated N2-Positive Non-Small Cell lung cancer.
Rei J; Castro P; Guerra M; Miranda J
Port J Card Thorac Vasc Surg; 2024 Feb; 30(4):23-29. PubMed ID: 38345887
[TBL] [Abstract] [Full Text] [Related]
13. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
14. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract] [Full Text] [Related]
15. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
[TBL] [Abstract] [Full Text] [Related]
16. Secondary Analysis of the Rate of Second Primary lung cancer From cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell lung cancer.
Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
[No Abstract] [Full Text] [Related]
17. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell lung cancer: A Nonrandomized Controlled Trial.
Wu TC; Luterstein E; Neilsen BK; Goldman JW; Garon EB; Lee JM; Felix C; Cao M; Tenn SE; Low DA; Kupelian PA; Steinberg ML; Lee P
JAMA Oncol; 2024 Mar; 10(3):352-359. PubMed ID: 38206614
[TBL] [Abstract] [Full Text] [Related]
18. Sublobar resection is associated with less lymph nodes examined and lower delivery of adjuvant therapy in patients with 1.5- to 2.0-cm clinical IA2 non-small-cell lung cancer: a retrospective cohort study.
Rodriguez-Quintero JH; Kamel MK; Jindani R; Vimolratana M; Chudgar NP; Stiles BM
Eur J Cardiothorac Surg; 2024 Jan; 65(1):. PubMed ID: 38147358
[TBL] [Abstract] [Full Text] [Related]
19. Impact of preoperative [
Lin JT; Li XM; Zhong WZ; Hou QY; Liu CL; Yu XY; Ye KY; Cheng YL; Du JY; Sun YQ; Zhang FG; Yan HH; Liao RQ; Dong S; Jiang BY; Liu SY; Wu YL; Yang XN
Ann Nucl Med; 2024 Mar; 38(3):188-198. PubMed ID: 38145431
[TBL] [Abstract] [Full Text] [Related]
20. Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
[Next]
